One IPOs and one SPACs went public in the week of March 21, 2022 led by AN2 Therapeutics (NASDAQ: ANTX), phase 2/3-ready biotech developing an in-licensed therapy for NTM lung disease, raised $69 million at a $296 million market cap and finished 3% above its IPO price.
The one SPACs went public this past week are:
1. RF Acquisition (new economy businesses in Southeast Asia SPAC)
Together, all the SPACs raised a total of $100 million.
#ipo #nasdaq #nyse #capitalmarket #hexcellence #spac #weeklyipo #recap
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected]